Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1 MB, PDF-dokument

  • Vivian Vij
  • Ignacio Cruz-González
  • Roberto Galea
  • Kerstin Piayda
  • Dominik Nelles
  • Lara Vogt
  • Steffen Gloekler
  • Monika Fürholz
  • Bernhard Meier
  • Lorenz Räber
  • Gilles O’Hara
  • Dabit Arzamendi
  • Victor Agudelo
  • Lluis Asmarats
  • Xavier Freixa
  • Eduardo Flores-Umanzor
  • Luis Nombela-Franco
  • Angela McInerney
  • Pablo Salinas
  • Kasper Korsholm
  • Jens Erik Nielsen-Kudsk
  • Shazia Afzal
  • Tobias Zeus
  • Felix Operhalski
  • Boris Schmidt
  • Gilles Montalescot
  • Paul Guedeney
  • Xavier Iriart
  • Noelie Miton
  • Jacqueline Saw
  • Thomas Gilhofer
  • Laurent Fauchier
  • Egzon Veliqi
  • Felix Meincke
  • Nils Petri
  • Peter Nordbeck
  • Rocio Gonzalez-Ferreiro
  • Deepak L. Bhatt
  • Alessandra Laricchia
  • Antonio Mangieri
  • Heyder Omran
  • Jan Wilko Schrickel
  • Josep Rodes-Cabau
  • Georg Nickenig
  • Horst Sievert
  • Alexander Sedaghat
Background
Device-related thrombus (DRT) after left atrial appendage closure (LAAC) is associated with adverse outcomes, i.e. ischemic stroke or systemic embolism (SE). Data on predictors of stroke/SE in the context of DRT are limited.

Aims
This study aimed to identify predisposing factors for stroke/SE in DRT patients. In addition, the temporal connection of stroke/SE to DRT diagnosis was analyzed.

Methods
The EUROC-DRT registry included 176 patients, in whom DRT after LAAC were diagnosed. Patients with symptomatic DRT, defined as stroke/SE in the context of DRT diagnosis, were compared against patients with non-symptomatic DRT. Baseline characteristics, anti-thrombotic regimens, device position, and timing of stroke/SE were compared.

Results
Stroke/SE occurred in 25/176 (14.2%) patients diagnosed with DRT (symptomatic DRT). Stroke/SE occurred after a median of 198 days (IQR 37–558) after LAAC. In 45.8% stroke/SE occurred within one month before/after DRT diagnosis (DRT-related stroke). Patients with symptomatic DRT had lower left ventricular ejection fractions (50.0 ± 9.1% vs. 54.2 ± 11.0%, p = 0.03) and higher rates of non-paroxysmal atrial fibrillation (84.0% vs. 64.9%, p = 0.06). Other baseline parameters and device positions were not different. Most ischemic events occurred among patients with single antiplatelet therapy (50%), however, stroke/SE was also observed under dual antiplatelet therapy (25%) or oral anticoagulation (20%).

Conclusion
Stroke/SE are documented in 14.2% and occur both in close temporal relation to the DRT finding and chronologically independently therefrom. Identification of risk factors remains cumbersome, putting all DRT patients at substantial risk for stroke/SE. Further studies are necessary to minimize the risk of DRT and ischemic events.
OriginalsprogEngelsk
TidsskriftClinical Research in Cardiology
Vol/bind112
Sider (fra-til)1790-1799
Antal sider10
ISSN1861-0684
DOI
StatusUdgivet - 2023

Bibliografisk note

Publisher Copyright:
© 2023, The Author(s).

ID: 363356631